药物信息为TENORETIC (atenolol and chlorthalidone) (AstraZeneca Pharmaceuticals LP): DESCRIPTION
- DESCRIPTION
- PHARMACODYNAMICS
- PHARMACOKINETICS AND METABOLISM
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- PREGNANCY AND FETAL INJURY
- PEDIATRIC USE
- GERIATRIC USE
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Diseases/Conditions Related to TENORETIC (atenolol and chlorthalidone) (AstraZeneca Pharmaceuticals LP)
- 外部链接相关的TENORETIC (atenolol and chlorthalidone) (AstraZeneca Pharmaceuticals LP)
TENORETIC® (atenolol and chlorthalidone) is for the treatment of hypertension. It combines the antihypertensive activity of two agents: a beta1-selective (cardioselective) hydrophilic blocking agent (atenolol, TENORMIN®) and a monosulfonamyl diuretic (chlorthalidone). Atenolol is Benzeneacetamide, 4-[2'-hydroxy-3'-[(1-methylethyl) amino] propoxy]-.

Atenolol (free base) is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37° C. It is freely soluble in 1N HCl (300 mg/mL at 25°C) and less soluble in chloroform (3 mg/mL at 25°C).
Chlorthalidone is 2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl) benzene sulfonamide:

Chlorthalidone has a water solubility of 12 mg/100 mL at 20°C.
Each TENORETIC 100 Tablet contains:
Atenolol (TENORMIN®).......................................100 mg
Chlorthalidone........................................................ 25 mg
Each TENORETIC 50 Tablet contains:
Atenolol (TENORMIN®).........................................50 mg
Chlorthalidone..........................................................25 mg
Inactive ingredients: magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate.
- Drug Information Provided by National Library of Medicine (NLM).
